Gigamon, Inc. (GIMO) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/31/2026
- Wall Street ends higher as Amazon soothes AI jitters
- Amazon shares rally as cloud growth surges and spending outlook climbs
- Apple shares sink on disappointing September quarter sales outlook
- Novo Nordisk stock tumbles 10% as key trial misses goal
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- KBR names its Mission Technology Solutions spinoff Trinzic
- Wall Street ends sharply higher, lifted by soaring Microsoft
- SCYNEXIS (SCYX) Move Attributed to Morning Note from Brookline
- AbbVie (ABBV) Misses Q2 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
Needham & Company Raises Price Target to $39 Following Gigamon, Inc. (GIMO) 2Q Beat and Raise
July 24, 2015 8:26 AM EDTNeedham & Company reiterated a Buy rating on Gigamon (NYSE: GIMO), and raised the price target to $39.00 (from $38.00), following a 2Q15 beat and raise. GIMO reported revenues of $51.4M vs $49.86 consensus, and raised 2015 guidance to $212.8M (from $208.5M). EPS was reported at $0.16 vs $0.14 consensus. GIMO raised 2015 EPS guidance to... More
Trading Radar for 7/23: GM (GM), Visa (V), 3M (MMM), Caterpillar (CAT), Comcast (CMCSA), McDonald's (MCD) Report
July 22, 2015 3:01 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EDT
Earnings:
3M Co. (NYSE: MMM) - consensus EPS $2.00
A.O. Smith (NYSE: AOS) - consensus EPS $0.66
ABB Ltd. (NYSE: ABB) - consensus EPS $0.26
AMAG Pharma (Nasdaq: AMAG) - consensus EPS $1.13
Adeptus Health (Nasdaq:... More
